FLT4 and obesity disorder: Tackling the VEGFR-3 signaling axis in obesity has resulted in dichotomous effects on adipose inflammation with some studies worsening and others improving metabolism (Karaman et al., 2015, 2016; Chakraborty et al., 2019).